Table 2. Radiologically verified response to chemical pleurodesis with mitoxantrone.

Evaluation period	Response† (%)
	CR	PR§	OS‡	PD	LTF	NA
Post-pleurodesis (months)
1	3/17 (17.6)	12/17 (70.6)	15/17 (88.2)	2/17 (11.8)	0	4/21 (19.0)
2	1/13 (7.7)	6/13 (46.2)	7/13 (53.8)	5/13 (38.5)	1/13 (7.7)	8/21 (38.1)
3	0	5/11 (45.5)	5/11 (45.5)	5/11 (45.5)	1/11 (9.1)	10/21 (47.6)

^†, values are given as the number of patients with the response/number of patients alive at the follow-up period (%), except for NA (denominator = total number of patients); ^‡, OS: overall success = sum of CR (complete response) and PR (partial response); ^§, unsuccessful outcome (PD—progressive disease, LTF—lost to follow-up, NA—dead).